Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Systematic Review And Meta-analysis Of Tumor Biomarkers In Predicting Prognosis In Esophageal Cancer

M. Chen, J. Huang, Zhenli Zhu, J. Zhang, K. Li
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BackgroundEsophageal cancer (EC) is a frequently occurring cancer with poor prognosis despite combined therapeutic strategies. Many biomarkers have been proposed as predictors of adverse events. We sought to assess the prognostic value of biomarkers in predicting the overall survival of esophageal cancer and to help guide personalized cancer treatment to give patients the best chance at remission.MethodsWe conducted a systematic review and meta-analysis of the published literature to summarize evidence for the discriminatory ability of prognostic biomarkers for esophageal cancer. Relevant literature was identified using the PubMed database on April 11, 2012, and conformed to the REMARK criteria. The primary endpoint was overall survival and data were synthesized with hazard ratios (HRs).ResultsWe included 109 studies, exploring 13 different biomarkers, which were subjected to quantitative meta-analysis. Promising markers that emerged for the prediction of overall survival in esophageal squamous cell cancer included VEGF (18 eligible studies, n = 1476, HR = 1.85, 95% CI, 1.55-2.21), cyclin D1 (12 eligible studies, n = 1476, HR = 1.82, 95% CI, 1.50-2.20), Ki-67 (3 eligible studies, n = 308, HR = 1.11, 95% CI, 0.70-1.78) and squamous cell carcinoma antigen (5 eligible studies, n = 700, HR = 1.28, 95% CI, 0.97-1.69); prognostic markers for esophageal adenocarcinoma included COX-2 (2 eligible studies, n = 235, HR = 3.06, 95% CI, 2.01-4.65) and HER-2 (3 eligible studies, n = 291, HR = 2.15, 95% CI, 1.39-3.33); prognostic markers for uncategorized ECs included p21 (9 eligible studies, n = 858, HR = 1.27, 95% CI, 0.75-2.16), p53 (31 eligible studies, n = 2851, HR = 1.34, 95% CI, 1.21-1.48), CRP (8 eligible studies, n = 1382, HR = 2.65, 95% CI, 1.64-4.27) and hemoglobin (5 eligible studies, n = 544, HR = 0.91, 95% CI, 0.83-1.00).ConclusionsAlthough some modest bias cannot be excluded, this review supports the involvement of biomarkers to be associated with EC overall survival.
This paper references
10.1093/jjco/hyp079
Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
P. Liu (2009)
10.1002/ijc.21923
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma
A. Rosato (2006)
10.1067/MSY.2000.105028
Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers.
H. Shiozaki (2000)
10.1002/IJC.2910630314
Prognostic value of DNA index, S‐phase fraction and p53 protein accumulation after surgical resection of esophageal squamous‐cell carcinomas in Thailand
A. Chanvitan (1995)
10.1093/jnci/djp038
Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.
B. G. Gould Rothberg (2009)
Associ - ation of p 53 / p 21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients
N Taghavi (2010)
10.1016/S0959-8049(97)84896-4
Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome.
J. Pomp (1998)
10.1002/ijc.10850
Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis
D. Güner (2003)
10.1111/j.1442-2050.2007.00750.x
Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
S. Zenda (2008)
Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
C. H. Shih (2000)
10.3748/WJG.V12.I23.3746
Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
I. Gockel (2006)
Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
西岡 清訓 (2002)
Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
C. Kunisaki (2006)
10.1002/cncr.10542
Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma
S. Takeno (2002)
Expression of cell cycle regulators p 21 and p 27 as predictors of disease outcome in colorectal carcin
J Al-Maghrabi (2012)
10.1016/j.ejcts.2009.05.056
Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression.
S. Takeno (2010)
10.3748/WJG.V9.I2.225
Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
Xi-jiang Zhao (2003)
10.1111/j.1442-2050.2008.00921.x
Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
K-F Hsu (2009)
Immunohistochemical evaluation for P 53 and VEGF ( Vascular Endothelial Growth Factor ) is not prognostic for long term survival in end stage esophageal adenocarcinoma
Arlos
p 21 Waf 1 / Cip 1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma , but not p 27 Kip 1 , p 53 , or Rb
ME Nita (1999)
10.1038/sj.bjc.6602499
Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma
K. Mimura (2005)
10.1046/J.1442-2050.2002.00226.X
Cell cycle-regulated factors in esophageal cancer.
M. Shinohara (2002)
10.1309/WJL90JPEM17RBUHT
E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications.
S. Takeno (2004)
10.1111/j.1442-2050.2011.01219.x
Clinicopathological significance of cyclooxygenase-2 and cell cycle-regulatory proteins expression in patients with esophageal squamous cell carcinoma.
J. Huang (2012)
Expression of hypoxia - inducible factor ( HIF ) - 1 alpha and vascular endothelial growth factor ( VEGF ) - D as outcome predictors in resected esophageal squamous cell carcinoma
C Tzao (2008)
10.1002/jcp.21223
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
H. Hugo (2007)
10.1038/sj.bjc.6600129
Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma
H. Shimada (2002)
10.1111/j.1442-2050.2010.01093.x
Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma.
Y. Chung (2011)
10.1007/s00268-010-0829-1
Mucin 1 and Vascular Endothelial Growth Factor C Expression Correlates with Lymph Node Metastatic Recurrence in Patients with N0 Esophageal Cancer After Ivor-Lewis Esophagectomy
Z. Sun (2010)
Clinical significance of serum carci - noembryonic antigen , carbohydrate antigen 19 – 9 , and squamous cell carcinoma antigen levels in esophageal cancer patients
S Kosugi (2004)
10.1158/1078-0432.CCR-11-2272
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
H. Yoon (2012)
10.1002/JSO.10275
Elevation of preoperative serum C‐reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma
H. Shimada (2003)
alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
T. Setoyama (2007)
Nuclear expression of 14-3-3 sigma is related to prognosis in patients with esophageal squamous cell carcinoma.
H. Okumura (2010)
10.1038/nrc2347
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
I. Chu (2008)
Prognostic significance of cyclinD 1 amplification and the co - alteration of cyclinD 1 / pRb / ppRb in patients with esophageal squamous cell carcinoma
A Chanvitan (2012)
10.2217/pgs.09.164
Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma.
A. Hoffmann (2010)
10.1016/S0002-9610(01)00684-5
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.
T. Nozoe (2001)
10.1016/S0003-4975(02)03641-X
Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma.
T. Noguchi (2002)
Prog - nostic significance of CyclinD 1 and E - Cadherin in patients with esophageal squamous cell carcinoma : multiinstitutional retrospective analysis
M Ikeguchi (2001)
10.1007/s00268-003-6866-2
Expression of Vascular Endothelial Growth Factor as a Prognostic Factor in Node-positive Squamous Cell Carcinoma in the Thoracic Esophagus: Long-term Follow-up Study
Y. Ogata (2003)
10.1097/01.sla.0000080822.22415.cb
Significant Host- and Tumor-Related Factors for Predicting Prognosis in Patients With Esophageal Carcinoma
M. Ikeda (2003)
10.1136/bmj.315.7109.629
Bias in meta-analysis detected by a simple, graphical test
M. Egger (1997)
10.1186/1756-9966-28-158
Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma
K. Sasaki (2009)
10.1136/bmj.327.7414.557
Measuring inconsistency in meta-analyses
J. Higgins (2003)
Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
T. Nakamura (2004)
10.1186/1471-2407-13-539
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
M. Chen (2013)
Prolyl isomerase Pin 1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD 1 expression
M. Fukuchi
10.1067/MSY.2003.139
Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
H. Shimada (2003)
Correlation of p 53 , MDM 2 and p 14 ( ARF ) protein expression in human esophageal squamous cell carcinoma
Cheng T-H (2009)
Cyclin D 1 overexpression as a prognostic factor in patients with esophageal carcinoma
M Shinohara (2001)
10.1007/PL00000826
Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancers
M. Lee (2001)
10.1038/sj.bjc.6602730
REporting recommendations for tumour MARKer prognostic studies (REMARK)
A. Harris (2005)
10.1159/000080289
Prognostic Significance of Dysadherin Expression in Esophageal Squamous Cell Carcinoma
Y. Shimada (2004)
Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
A. Bergqvist (2001)
10.1159/000049366
Prognostic Value of Serum Tumor Markers in Patients with Lung Cancer
K. Hatzakis (2002)
10.1016/j.cell.2011.02.013
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)
10.1111/j.1442-2050.2007.00749.x
Prognostic value of cell adhesion in esophageal adenocarcinomas.
D. Falkenback (2008)
10.1016/J.AMJSURG.2004.03.019
Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus.
T. Nozoe (2005)
10.1159/000081001
Prognostic Significance of Serine 392 Phosphorylation in Overexpressed p53 Protein in Human Esophageal Squamous Cell Carcinoma
M. Matsumoto (2004)
10.1002/ijc.21134
Prognostic role of cyclooxygenase‐2 in neoadjuvant‐treated patients with squamous cell carcinoma of the esophagus
A. Sivula (2005)
Micro - vessel density and VEGF expression are prognostic factors in colorectal cancer . Meta - analysis of the literature
G DesGuetz (2006)
Prediction of CCND 1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
MT Wang (2010)
10.1038/bjc.1998.281
In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.
S. Uchida (1998)
10.1111/J.1442-2050.2006.00570.X
HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival.
M. Dreilich (2006)
10.1111/J.1442-2050.2006.00604.X
Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.
S. Mega (2006)
10.1093/JJCO/HYM077
Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
T. Kii (2007)
10.1002/(SICI)1096-9098(199910)72:2<94::AID-JSO10>3.0.CO;2-9
No prognostic significance of p53 expression in esophageal squamous cell carcinoma
A. Kanamoto (1999)
10.1007/s00432-011-1057-2
Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis
J. Chen (2011)
10.1159/000012067
Prognostic Value of p27Kip1 and CyclinD1 Expression in Esophageal Cancer
A. Itami (1999)
10.1016/S0003-4975(01)02838-7
Tumor marker expression is predictive of survival in patients with esophageal cancer.
T. Aloia (2001)
10.1385/MO:22:1:029
The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma
M. Dreilich (2005)
10.1371/journal.pone.0023985
Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma
D. Berg (2011)
Cyclin D 1 expression and retinoblastoma gene protein ( pRB ) expression in esophageal squamous cell carcin
S Nagasawa (2001)
p 53 Mutational Status Improves Estimation of Prognosis in Patients with Curatively Resected Adenocarcinoma in Barrett ’ s Esophagus 1
P. Schneider (2000)
10.1136/bmj.323.7306.224
Systematic reviews of evaluations of prognostic variables
D. Altman (2001)
10.3892/OR.17.3.517
Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.
S. Natsugoe (2007)
p 53 alterations in oesophageal cancer : association with clinicopatho - logical features , risk factors , and survival
J Pomp (1998)
Prognostic significance of serum p 53 antibody in patients with esophageal squamous cell carcinoma
H Shimada (2002)
10.1186/1471-2407-6-134
Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
P. Bhandari (2005)
10.1046/J.1442-2050.1999.00031.X
The prognostic significance of cell cycle markers in esophageal cancer after neoadjuvant chemotherapy.
M. Yasunaga (1999)
10.1038/nrc2293
Survivin, cancer networks and pathway-directed drug discovery
D. Altieri (2008)
10.1007/s00066-008-1850-2
Impact of VEGF and VEGF Receptor 1 (FLT1) Expression on the Prognosis of Stage III Esophageal Cancer Patients after Radiochemotherapy*
D. Rades (2008)
Positive correlation between p 27 Kip 1 expression and progression of human esophageal squamous cell carcinoma
T Anayama (1998)
10.1158/1078-0432.CCR-07-0465
Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues
S. Rauser (2007)
10.1016/j.jtcvs.2007.11.007
Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Po-Kuei Hsu (2008)
Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
H. Kato (2002)
10.1183/09031936.01.00062201
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.
E. Steels (2001)
10.1007/s00268-008-9821-4
Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma
H. Shimada (2008)
The prognostic significance of p 53 , p 21 ( Waf 1 / Cip 1 ) , and cyclin D 1 protein expression in esophageal cancer patients
T Hirai (1999)
Prognostic value of p 53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus
AR Rosa (2003)
Expression of RCAS 1 in esophageal squamous cell carcinoma is associated with a poor prognosis
H Kato (2005)
10.1016/0197-2456(86)90046-2
Meta-analysis in clinical trials.
R. Dersimonian (1986)
10.1007/s11605-009-1113-2
Association of C-Reactive Protein Levels and Long-Term Survival after Neoadjuvant Therapy and Esophagectomy for Esophageal Cancer
U. Zingg (2009)
10.1007/S12094-006-0091-Z
Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy
J. Valencia Julve (2006)
10.1159/000070659
Survivin Gene Expression Positively Correlates with Proliferative Activity of Cancer Cells in Esophageal Cancer
M. Ikeguchi (2003)
Expression of p 21 WAF 1 / Cip 1 in the p 53-dependent Pathway Is Related to Prognosis in Patients with Advanced Esophageal Carcinoma 1
S. Natsugoe (1999)
10.1007/S11912-002-0023-1
The role of C-reactive protein as a prognostic indicator in advanced cancer
Fade Mahmoud (2002)
10.1053/GAST.2002.33580
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
C. Buskens (2002)
10.1002/1097-0142(20010801)92:3<663::AID-CNCR1368>3.0.CO;2-L
Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma
H. Shimada (2001)
Deregulated p 21 ( WAF 1 ) over - expression impacts survival of surgically resected esophageal squamous cell carcinoma patients
Goan Y-G (2005)
10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0
Prognostic value of DNA ploidy and cerbB‐2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus
T. Nakamura (1994)
10.1002/jso.21855
PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery
C. Yen (2011)
Loss of p 27 ( KIP 1 ) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma
A Shamma (2000)
10.1186/1471-2407-12-119
Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy
P. Blanchard (2011)
10.1006/GYNO.2000.5732
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
K. Gaarenstroom (2000)
10.1186/1756-9966-29-83
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis
T. Tanaka (2010)
10.1245/ASO.2006.08.012
Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Esophageal Squamous Cell Carcinoma: Comparison With Positron Emission Tomography
J. Choi (2006)
10.2307/2533446
Operating characteristics of a rank correlation test for publication bias.
C. Begg (1994)
10.1016/j.radonc.2009.01.002
Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy.
Chang-Yu Wang (2009)
10.1016/S0304-3835(02)00630-4
Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker.
T. Nozoe (2003)
10.3346/jkms.2011.26.4.513
VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
M. Yoon (2011)
10.1159/000086961
Clinical Significance of Osteopontin in Esophageal Squamous Cell Carcinoma: Comparison with Common Tumor Markers
Y. Shimada (2005)
10.1038/sj.bjc.6990499
Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology
Y. Shimada (1999)
10.1371/journal.pmed.1000286
Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease
H. Hemingway (2010)
Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis.
F. Song (1998)
10.1046/J.1442-2050.1999.00034.X
p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer.
M. Kuwahara (1999)
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
M. Sarbia (1998)
10.3346/JKMS.2002.17.2.201
Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas.
M. Ahn (2002)
p 53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus
M Yamasaki (2010)
Intratumoral lym - phangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis
A Inoue (2008)
10.1002/(SICI)1097-0215(19990219)84:1<86::AID-IJC16>3.0.CO;2-7
Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities
M. Sarbia (1999)
10.1007/s13277-009-0001-4
COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer
J. Mrena (2009)
10.3892/OR.9.1.23
Prognostic significance of thymidine phosphorylase and p53 co-expression in esophageal squamous cell carcinoma.
Oota Makoto (2002)
10.1111/J.1442-2050.2005.00504.X
Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma.
D. Brattström (2005)
Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.
M. Gibson (2003)
10.1111/j.1349-7006.2003.tb01485.x
Cell adhesion system and human cancer morphogenesis
S. Hirohashi (2003)
10.1016/j.ejcts.2010.01.061
Serum vascular endothelial growth factors C and D in patients with oesophageal cancer.
M. Kozlowski (2010)
10.1007/s00595-012-0147-3
Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes
Toshinobu Nakatsu (2012)



This paper is referenced by
10.1007/s13304-019-00696-3
Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer
A. Fountoulakis (2019)
10.1155/2020/6520259
Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis
Junbo Wu (2020)
Factores pronósticos asociados a la supervivencia en el cáncer de esófago
Elena Rodríguez Camacho (2014)
10.3978/j.issn.2305-5839.2015.12.34
Analytical assessment of the novel Maglumi squamous cell carcinoma antigen (SCCA) immunoluminometric assay.
Mariella Dipalo (2015)
10.1371/journal.pone.0161418
Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women
W. Wulaningsih (2016)
Diabetes and Incidence and Prognosis of Surgical Malignancies
Kirstin de Bruijn (2015)
10.18632/oncotarget.4800
Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma
Dan-hong Zhang (2015)
10.1016/j.mgene.2020.100734
The prognostic implication of pre-treatment hemoglobin levels in esophageal cancer patients: A systematic review and meta-analysis
Zihan Ran (2020)
10.1586/17474124.2015.1041507
Prognostic markers in esophageal cancer: from basic research to clinical use
L. Hong (2015)
10.1007/s10552-015-0646-9
Africa’s oesophageal cancer corridor: Do hot beverages contribute?
M. O. Munishi (2015)
10.2188/jea.JE20140118
Clinical-Pathological Characteristics and Prognosis of a Cohort of Oesophageal Cancer Patients: a Competing Risks Survival Analysis
E. Rodríguez-Camacho (2015)
10.18632/oncotarget.8868
Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma
F. Zhang (2016)
10.1186/s40880-017-0232-5
Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review
Chunni Wang (2017)
10.33160/yam.2020.02.002
Prognostic Significance of C-reactive Protein-to-prealbumin Ratio in Patients with Esophageal Cancer.
T. Matsunaga (2020)
10.1177/0003489415590657
Local Synthesis of Pepsin in Barrett’s Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma
T. Samuels (2015)
10.1055/s-0044-101352
Lessons from pathological analysis of recurrent early esophageal squamous cell neoplasia after complete endoscopic radiofrequency ablation.
W. Wang (2018)
10.1097/SPC.0000000000000056
Opioids and cancer recurrence
R. Juneja (2014)
10.1093/dote/doy057
High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
Shu-yan Sun (2019)
10.1038/bjc.2015.460
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
LH McCormick Matthews (2015)
10.1111/ecc.12446
Tumour‐associated antigens and their anti‐cancer applications
C. Liu (2017)
10.3978/j.issn.2078-6891.2014.107
HER2 expression in gastric and oesophageal cancer: a meta-analytic review.
V. Nagaraja (2015)
10.18632/oncotarget.15645
Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma
Z. Tong (2017)
10.1186/1471-2407-13-539
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
M. Chen (2013)
10.2147/CMAR.S212192
Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study
Y. Zheng (2019)
10.1186/s12885-015-1524-2
Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies
Song Wen (2015)
Prognostic role of human papillomavirus in esophageal cancer : a meta-analysis
T. Zheng (2016)
10.1016/j.jamcollsurg.2016.12.003
Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance?
Syeda Nadia Shah Gilani (2017)
10.1002/jso.23923
Absence or low IGF‐1R‐expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection
K. D. De Bruijn (2015)
The prognostic value of TP 53 mutations in oesophageal adenocarcinoma : a systematic review and meta-analysis
O. Fisher (2016)
10.3892/or.2017.5681
Construction of disease-specific transcriptional regulatory networks identifies co-activation of four gene in esophageal squamous cell carcinoma.
Y. Zhao (2017)
10.3978/j.issn.2078-6891.2014.093
Systemic treatment of gastric and esophageal adenocarcinoma in elderly patients.
L. Balducci (2015)
10.1016/j.omtn.2019.10.037
miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo
C. Yang (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar